D-0020-2015 Class I Terminated
FDA drug recall D-0020-2015 was initiated by Hospira Inc. on Jul 29, 2014 and is designated Class I. Reason for recall: Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial. The recall status is terminated (terminated Mar 17, 2017). Affected quantity: 109,110 Vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 22, 2014
- Initiation Date
- Jul 29, 2014
- Termination Date
- Mar 17, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 109,110 Vials
Product Description
Lidocaine HCl Injection, USP, 2%, 20 mg per mL, Preservative-Free, 5 mL Single-Dose Vial, Rx only, For Infiltration and Nerve Block including Epidural and Caudal, Manufactured by: Hospira, Inc., Lake Forest, IL, 60045, NDC 0409-2066-05
Reason for Recall
Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.
Distribution Pattern
Nationwide
Code Information
Lot Number: 25-550-DD, Exp: 1JAN2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0020-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026